Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| Revenues | 3,279.2 | 2,991.1 | 2,937.8 | 2,299.5 | 2,207.3 | 1,903.0 | 2,004.1 | 1,764.8 |
| Revenue growth | 9.6% | 1.8% | 27.8% | 4.2% | 16.0% | -5.0% | 13.6% | -32.8% |
| Cost of goods sold | 1,693.2 | 1,598.8 | 1,503.3 | 1,228.2 | 1,065.9 | 933.7 | 795.5 | 728.1 |
| Gross profit | 1,586.0 | 1,392.3 | 1,434.5 | 1,071.3 | 1,141.3 | 969.3 | 1,208.6 | 1,036.7 |
| Gross margin | 48.4% | 46.5% | 48.8% | 46.6% | 51.7% | 50.9% | 60.3% | 58.7% |
| Selling, general and administrative | 474.6 | 464.6 | 438.9 | 406.9 | 367.8 | 342.3 | 389.7 | 379.2 |
| General and administrative | 60.1 | 68.1 | 73.3 | 80.1 | 52.5 | 54.9 | 58.7 | 61.0 |
| EBITA | 1,046.0 | 855.5 | 949.1 | 619.3 | 744.2 | 619.1 | 841.2 | 757.7 |
| EBITA margin | 31.9% | 28.6% | 32.3% | 26.9% | 33.7% | 32.5% | 42.0% | 42.9% |
| Amortization of intangibles | 59.9 | 63.0 | 67.7 | 50.1 | 30.8 | 61.9 | 115.0 | 121.3 |
| EBIT | 986.2 | 792.5 | 881.4 | 569.2 | 713.4 | 557.2 | 726.2 | 636.4 |
| EBIT margin | 30.1% | 26.5% | 30.0% | 24.8% | 32.3% | 29.3% | 36.2% | 36.1% |
| Pre-tax income | 1,035.9 | 749.2 | 791.3 | 375.7 | 508.7 | 310.7 | 449.3 | 345.7 |
| Income taxes | 202.4 | 135.5 | 154.3 | 89.4 | 107.4 | -137.2 | 140.2 | 116.1 |
| Tax rate | 19.5% | 18.1% | 19.5% | 23.8% | 21.1% | | 31.2% | 33.6% |
| Earnings from continuing ops | 834.3 | 614.9 | 637.0 | 286.2 | 401.3 | 954.6 | 257.8 | 166.4 |
| Earnings from discontinued ops | | | | | 4.3 | -232.9 | 178.9 | 293.1 |
| Net income | 834.3 | 614.9 | 637.0 | 286.2 | 405.7 | 721.7 | 436.7 | 459.5 |
| Net margin | 25.4% | 20.6% | 21.7% | 12.4% | 18.4% | 37.9% | 21.8% | 26.0% |
| |
| Diluted EPS | $3.72 | $2.76 | $2.90 | $1.31 | $1.85 | $4.39 | $1.17 | $0.72 |
| Shares outstanding (diluted) | 224.5 | 222.5 | 219.7 | 218.0 | 216.6 | 217.5 | 219.7 | 229.7 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|